Pallas Capital Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$122K Sell
26,430
-22,141
-46% -$115K ﹤0.01% 793
2025
Q4
$243K Buy
48,571
+12,687
+35% +$66K 0.01% 756
2025
Q3
$182K Buy
+35,884
New +$158K 0.01% 796
2022
Q4
Sell
-129,099
Closed -$1.43M 284
2022
Q3
$1.43M Buy
129,099
+10,463
+9% +$158K 0.16% 101
2022
Q2
$1.96M Buy
118,636
+16,903
+17% +$304K 0.27% 72
2022
Q1
$2.06M Buy
101,733
+15,442
+18% +$333K 0.26% 74
2021
Q4
$1.98M Buy
86,291
+4,961
+6% +$106K 0.24% 75
2021
Q3
$1.72M Buy
81,330
+23,268
+40% +$477K 0.19% 96
2021
Q2
$1.17M Buy
58,062
+7,627
+15% +$163K 0.16% 107
2021
Q1
$1.08M Buy
+50,435
New +$1.08M 0.24% 71

Other funds holding MPT

Pallas Capital Advisors's MPT Position: Q1 2026 in Review

Pallas Capital Advisors reduced its Medical Properties Trust (MPT) stake by 46% in Q1 2026, selling an estimated $115K and leaving 26,430 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #793.

Pallas Capital Advisors first reported a position in MPT in Q1 2021 and has held it in 10 quarters since. The position peaked at $2.06M in Q1 2022. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Pallas Capital Advisors held 26,430 shares of Medical Properties Trust worth $122K as of Q1 2026.
  • Pallas Capital Advisors sold 22,141 Medical Properties Trust shares in Q1 2026, an estimated $115K.
  • Medical Properties Trust made up ﹤0.01% of Pallas Capital Advisors's portfolio in Q1 2026, its #793 holding.
  • Pallas Capital Advisors first reported a position in Medical Properties Trust in Q1 2021 and has held it in 10 quarters since.
  • Pallas Capital Advisors's Medical Properties Trust position peaked at $2.06M in Q1 2022.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.